Tamoxifen induced-thrombocytopenia: it does occur

Nasiroglu N., Pamukcuoglu M., Abali H., Oeksuezoglu B., Uener A., Zengin N.

MEDICAL ONCOLOGY, cilt.24, sa.4, ss.453-454, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 24 Sayı: 4
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1007/s12032-007-0013-0
  • Dergi Adı: MEDICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.453-454
  • Hacettepe Üniversitesi Adresli: Hayır

Özet

Tamoxifen has been in the center of management of hormone-sensitive breast cancer. Furthermore, it represents the best example of chemo-prevention: It reduces the incidence of invasive breast cancer. However, it has some side effects, several of them are severe. Oncologists, hematologists, internal medicine specialists and gynecologists must know this agent in detail. Authors report a very rare side effect, thrombocytopenia and discuss it briefly.